Ripon Advance (04/25/18)
Bipartisan legislation introduced by U.S. Rep. Susan Brooks (R-Ind.) on April 23 calls for medical practitioners to meet certain continuing medical education (CME) requirements if they prescribe controlled substances such as opioids. States could set even more training obligations under the proposed Abuse Deterrent And Prescriber Training (ADAPT) Act of 2018 (H.R.5581). The bill would mandate CME training for medical providers on safe-prescribing guidelines, opioid analgesic risks, alternative pain management options, early detection of opioid addiction, and addiction treatment options, according to a summary provided by Brooks' office. If enacted, the legislation would require the Government Accountability Office (GAO) to study and report to Congress on how CME affects prescribing practices. In addition, the GAO would be called on to examine how much CME reduces opioid prescriptions, overdoses, and deaths associated with opioid abuse. Also under H.R. 5581, states would have the flexibility to approve their own training requirements, which could be based on best practices established by the U.S. Department of Health and Human Services, the summary said. U.S. Rep. Brad Schneider (D-Ill.) joined Rep. Brooks in unveiling H.R. 5581, which has been referred to the U.S. House Energy and Commerce Committee and the U.S. House Judiciary Committee.